Search reports.
North America Nuclear Medicine Market Share, Industry | 2031
Get free sample report Request for Customiztion Buy Now

North America Nuclear Medicine Market Share, Industry | 2031

Segments - North America Nuclear Medicine Market by Product Types (Diagnostics [Single Photon Emission Computed Tomography (SPECT) and Photon Emission Tomography (PET)] and Therapeutics [Alpha Emitters, Beta Emitters, and Brachytherapy]), Applications (Cardiology, Neurology, Oncology, and Others), and Geography (The US, Canada, and Mexico) - Industry Analysis, Growth, Share, Size, Trends, and Forecast 2023 - 2031

https://growthmarketreports.com/raksha
Author : Raksha Sharma
https://growthmarketreports.com/Vaibhav
Fact-checked by : V. Chandola
https://growthmarketreports.com/Vishal
Editor : Vishal Golekar

Upcoming | Report ID :HC-3453 | 4.4 Rating | 70 Reviews | 167 Pages | Format : PDF Excel PPT

Report Description


North America Nuclear Medicine Market Outlook 2031:

The North America nuclear medicine market size was valued at USD 3.02 Billion in 2022 and is projected to reach USD 5.60 Billion by 2031, expanding at a CAGR of 7.1% during the forecast period 2023 - 2031. The growth of the market is attributed to rising incidence and prevalence of cancer and cardiovascular disease.

Nuclear medicine is used to diagnose a wide range of conditions. It uses small amounts of radioactive material called radiopharmaceuticals. Doctors use nuclear medicine to diagnose, appraise, and treat various diseases such as cancer, heart disease, gastrointestinal, endocrine, and neurological disorders. The radiopharmaceuticals are allocated to the patient by hypodermic injection, orally, or by other routes depending on the organ.

North America Nuclear Medicine Market Outlook

During the COVID-19 pandemic, the nuclear medicine market was negatively impacted due to academic medical centers and universities were rushed to shut down scientific research activities to maximize social distancing and minimize the spread of infection to research staff.

  • Rising geriatric population is anticipated to drive the market growth during the forecast period.
  • Increasing requirement for personalized medicines among healthcare professionals and patients is projected to boost the market growth in the coming years.
  • Growing various technological advancements, such as the development of data integrated imaging systems and radiotracers, is expected to spur the market growth during the forecast period.
  • Increasing awareness regarding the potential impact of early and timely diagnosis is anticipated to drive the market growth during the forecast period.
  • Rising demand for nuclear imaging is projected to boost the market growth in the coming years.
  • Expanding incidence of cardiac patients and adoption of clear imaging technique is expected to spur the market growth during the forecast period.
  • Short half-life of radiopharmaceuticals can restrain the market growth.
  • Hospital budget cuts and high equipment costs can create challenges for the market growth.
  • Rising use of radiopharmaceuticals in neurological applications can create lucrative opportunities during the forecast period.

Scope of Nuclear Medicine Market Report

The report on the North America nuclear medicine market includes an assessment of the market, trends, segments, and regional markets. Overview and dynamics have also been included in the report.

Attributes

Details

Report Title

North America Nuclear Medicine Market - Industry Analysis, Growth, Share, Size, Trends, and Forecast

Base Year

2022

Historic Data

2016–2021

Forecast Period

2023–2031

Segmentation

Product Types (Diagnostics [Single Photon Emission Computed Tomography (SPECT) and Photon Emission Tomography (PET)] and Therapeutics [Alpha Emitters, Beta Emitters, and Brachytherapy]), and Applications (Cardiology, Neurology, Oncology, and Others)

Geography

The US, Canada, and Mexico

Report Coverage

Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, and Trends, and Revenue Forecast

Key Players Covered in the Report

Siemens Healthineers AG; GE Healthcare (GE Company); Cardinal Health; Sotera Health (Nordion Inc.); and Curium Pharma

North America Nuclear Medicine Market Segment Insights

Single photon emission computed tomography sub-segment to hold a significant market share

Based on product types, the market is divided into diagnostics and therapeutics. The diagnostics segment is segregated into single photon emission computed tomography (SPECT) and photon emission tomography (PET). The therapeutics segment is further segmented into alpha emitters, beta emitters, and brachytherapy.

The photon emission tomography sub-segment is anticipated to hold a key share of the market in the coming years due to their high imaging capabilities, shorter half-life, and increasing applications in the oncology area. However, the single photon emission computed tomography sub-segment is anticipated to expand at a rapid pace during the forecast period owing to its sheer procedural volume and higher reimbursement.

North America Nuclear Medicine Market Product Types

Oncology segment is anticipated to constitute a large market share

On the basis of applications, the market is segmented into cardiology, neurology, oncology, and others. The cardiology segment is projected to constitute a major market share during the forecast period.

On the other hand, the oncology segment is anticipated to expand at a rapid pace during the forecast period, as nuclear medicine enhances cancer detection and facilitate high speed noninvasive diagnosis using genomics and proteomics.

North America Nuclear Medicine Market Application

Canada is estimated to account a major market share

On the basis of geography, the market is classified as the US, Canada, and Mexico. The US is expected to constitute a key share of the market during the projected period due to adoption of advanced radiopharmaceuticals and recent product launches.

However, the market in Canada is anticipated expand at a rapid pace during the forecast period owing to increasing healthcare expenditure.

Segments

The North America nuclear medicine market has been segmented on the basis

Product Types

  • Diagnostics
    • Single Photon Emission Computed Tomography (SPECT)
    • Photon Emission Tomography (PET)]
  • Therapeutics
    • Alpha Emitters
    • Beta Emitters
    • Brachytherapy

Applications

  • Cardiology
  • Neurology
  • Oncology
  • Others

Geography

  • The US
  • Canada
  • Mexico

Key Players

Competitive Landscape

Key players competing in the North America nuclear medicine market includes Siemens Healthineers AG; GE Healthcare (GE Company); Cardinal Health; Sotera Health (Nordion Inc.); and Curium Pharma.

Some of these players are engaging in business strategies such as mergers, acquisitions, partnerships, collaborations, capacity expansion, and product launches to enhance their market share.

North America Nuclear Medicine Market Key Players

Table Of Content

1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Nuclear Medicine Market Overview
  4.1. Introduction
     4.1.1. Market Taxonomy
     4.1.2. Market Definition
  4.2. Macro-Economic Factors
     4.2.1. Industry Outlook
  4.3. Nuclear Medicine Market Dynamics
     4.3.1. Market Drivers
     4.3.2. Market Restraints
     4.3.3. Opportunity
     4.3.4. Market Trends
  4.4. Nuclear Medicine Market - Supply Chain
  4.5. Global Nuclear Medicine Market Forecast
     4.5.1. Nuclear Medicine Market Size (US$ Mn) and Y-o-Y Growth
     4.5.2. Nuclear Medicine Market Size (000’ Units) and Y-o-Y Growth
     4.5.3. Nuclear Medicine Market Absolute $ Opportunity
5. Global Nuclear Medicine Market Analysis and Forecast by Applications
  5.1. Market Trends
  5.2. Introduction
     5.2.1. Basis Point Share (BPS) Analysis by Applications
     5.2.2. Y-o-Y Growth Projections by Applications
  5.3. Nuclear Medicine Market Size and Volume Forecast by Applications
     5.3.1. Cardiology
     5.3.2. Neurology
     5.3.3. Oncology
     5.3.4. Others
  5.4. Absolute $ Opportunity Assessment by Applications
  5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Nuclear Medicine Market Analysis and Forecast by Region
  6.1. Market Trends
  6.2. Introduction
     6.2.1. Basis Point Share (BPS) Analysis by Region
     6.2.2. Y-o-Y Growth Projections by Region
  6.3. Nuclear Medicine Market Size and Volume Forecast by Region
     6.3.1. North America
     6.3.2. Latin America
     6.3.3. Europe
     6.3.4. Asia Pacific
     6.3.5. Middle East and Africa (MEA)
  6.4. Absolute $ Opportunity Assessment by Region
  6.5. Market Attractiveness/Growth Potential Analysis by Region
  6.6. Global Nuclear Medicine Demand Share Forecast, 2019-2026
7. North America Nuclear Medicine Market Analysis and Forecast
  7.1. Introduction
     7.1.1. Basis Point Share (BPS) Analysis by Country
     7.1.2. Y-o-Y Growth Projections by Country
  7.2. North America Nuclear Medicine Market Size and Volume Forecast by Country
     7.2.1. U.S.
     7.2.2. Canada
  7.3. Absolute $ Opportunity Assessment by Country
  7.4. North America Nuclear Medicine Market Size and Volume Forecast by Applications
     7.4.1. Cardiology
     7.4.2. Neurology
     7.4.3. Oncology
     7.4.4. Others
  7.5. Basis Point Share (BPS) Analysis by Applications
  7.6. Y-o-Y Growth Projections by Applications
  7.7. Market Attractiveness/Growth Potential Analysis
     7.7.1. By Country
     7.7.2. By Product Type
     7.7.3. By Application
  7.8. North America Nuclear Medicine Demand Share Forecast, 2019-2026
8. Latin America Nuclear Medicine Market Analysis and Forecast
  8.1. Introduction
     8.1.1. Basis Point Share (BPS) Analysis by Country
     8.1.2. Y-o-Y Growth Projections by Country
     8.1.3. Latin America Average Pricing Analysis
  8.2. Latin America Nuclear Medicine Market Size and Volume Forecast by Country
      8.2.1. Brazil
      8.2.2. Mexico
      8.2.3. Rest of Latin America
   8.3. Absolute $ Opportunity Assessment by Country
  8.4. Latin America Nuclear Medicine Market Size and Volume Forecast by Applications
     8.4.1. Cardiology
     8.4.2. Neurology
     8.4.3. Oncology
     8.4.4. Others
  8.5. Basis Point Share (BPS) Analysis by Applications
  8.6. Y-o-Y Growth Projections by Applications
  8.7. Market Attractiveness/Growth Potential Analysis
     8.7.1. By Country
     8.7.2. By Product Type
     8.7.3. By Application
  8.8. Latin America Nuclear Medicine Demand Share Forecast, 2019-2026
9. Europe Nuclear Medicine Market Analysis and Forecast
  9.1. Introduction
     9.1.1. Basis Point Share (BPS) Analysis by Country
     9.1.2. Y-o-Y Growth Projections by Country
     9.1.3. Europe Average Pricing Analysis
  9.2. Europe Nuclear Medicine Market Size and Volume Forecast by Country
     9.2.1. Germany
     9.2.2. France
     9.2.3. Italy
     9.2.4. U.K.
     9.2.5. Spain
     9.2.6. Russia
     9.2.7. Rest of Europe
  9.3. Absolute $ Opportunity Assessment by Country
  9.4. Europe Nuclear Medicine Market Size and Volume Forecast by Applications
     9.4.1. Cardiology
     9.4.2. Neurology
     9.4.3. Oncology
     9.4.4. Others
  9.5. Basis Point Share (BPS) Analysis by Applications
  9.6. Y-o-Y Growth Projections by Applications
  9.7. Market Attractiveness/Growth Potential Analysis
     9.7.1. By Country
     9.7.2. By Product Type
     9.7.3. By Application
  9.8. Europe Nuclear Medicine Demand Share Forecast, 2019-2026
10. Asia Pacific Nuclear Medicine Market Analysis and Forecast
  10.1. Introduction
     10.1.1. Basis Point Share (BPS) Analysis by Country
     10.1.2. Y-o-Y Growth Projections by Country
     10.1.3. Asia Pacific Average Pricing Analysis
  10.2. Asia Pacific Nuclear Medicine Market Size and Volume Forecast by Country
     10.2.1. China
     10.2.2. Japan
     10.2.3. South Korea
     10.2.4. India
     10.2.5. Australia
     10.2.6. Rest of Asia Pacific (APAC)
  10.3. Absolute $ Opportunity Assessment by Country
  10.4. Asia Pacific Nuclear Medicine Market Size and Volume Forecast by Applications
     10.4.1. Cardiology
     10.4.2. Neurology
     10.4.3. Oncology
     10.4.4. Others
  10.5. Basis Point Share (BPS) Analysis by Applications
  10.6. Y-o-Y Growth Projections by Applications
  10.7. Market Attractiveness/Growth Potential Analysis
     10.7.1. By Country
     10.7.2. By Product Type
     10.7.3. By Application
  10.8. Asia Pacific Nuclear Medicine Demand Share Forecast, 2019-2026
11. Middle East & Africa Nuclear Medicine Market Analysis and Forecast
  11.1. Introduction
     11.1.1. Basis Point Share (BPS) Analysis by Country
     11.1.2. Y-o-Y Growth Projections by Country
     11.1.3. Middle East & Africa Average Pricing Analysis
  11.2. Middle East & Africa Nuclear Medicine Market Size and Volume Forecast by Country
     11.2.1. Saudi Arabia
     11.2.2. South Africa
     11.2.3. UAE
     11.2.4. Rest of Middle East & Africa (MEA)
  11.3. Absolute $ Opportunity Assessment by Country
  11.4. Middle East & Africa Nuclear Medicine Market Size and Volume Forecast by Applications
     11.4.1. Cardiology
     11.4.2. Neurology
     11.4.3. Oncology
     11.4.4. Others
  11.5. Basis Point Share (BPS) Analysis by Applications
  11.6. Y-o-Y Growth Projections by Applications
  11.7. Market Attractiveness/Growth Potential Analysis
     11.7.1. By Country
     11.7.2. By Product Type
     11.7.3. By Application
  11.8. Middle East & Africa Nuclear Medicine Demand Share Forecast, 2019-2026
12. Competition Landscape
  12.1. Global Nuclear Medicine Market: Market Share Analysis
  12.2. Nuclear Medicine Distributors and Customers
  12.3. Nuclear Medicine Market: Competitive Dashboard
  12.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
     12.4.1. Siemens Healthineers AG
     12.4.2. GE Healthcare (GE Company)
     12.4.3. Cardinal Health
     12.4.4. Sotera Health (Nordion Inc.)
     12.4.5. Curium Pharma

Methodology

Our Clients

sinopec
Microsoft
Honda Motor Co. Ltd.
General Mills
The John Holland Group
Siemens Healthcare
Dassault Aviation
Nestle SA